サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：固形腫瘍検査の世界市場規模調査＆予測：タイプ別、用途別、最終用途別、地域別分析、2023-2030年
市場調査レポート
商品コード
1290515

固形腫瘍検査の世界市場規模調査＆予測：タイプ別、用途別、最終用途別、地域別分析、2023-2030年

Global Solid Tumor Testing Market Size study & Forecast, by Type, by Application, by End Use and Regional Analysis, 2023-2030

出版日
ページ情報
英文
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.76円
固形腫瘍検査の世界市場規模調査＆予測：タイプ別、用途別、最終用途別、地域別分析、2023-2030年
出版日: 2023年06月10日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の固形腫瘍検査市場は、2022年に約254億7,000万米ドルと評価され、予測期間2023-2030年には7.0%以上の健全な成長率で成長すると予測されています。

固形腫瘍は、液体や嚢胞を含まない、制御不能な細胞の発生として特徴付けられます。腫瘍の早期診断のために、固形腫瘍検査が使用されます。固形腫瘍の生物学に関する重要な調査や固形腫瘍を検出するための検査開発にもかかわらず、固形腫瘍は依然として主要な死因の1つとなっています。固形腫瘍の診断には、遺伝子検査と従来型検査の2つの方法が用いられています。固形腫瘍検査市場は、がんの有病率の上昇や卵巣がん、膵臓がん、前立腺がんにおける新製品の承認などの要因によって拡大しています。

国際がん研究機関（IARC）の予測によると、世界におけるがんの新規発生件数は、2021年の190万件から2040年には2750万件に達すると予測されており、世界のがんの蔓延が市場の成長を促しています。また、がん啓発のための政府の取り組みが増加し、医療インフラが発達していることが、市場の有利な成長を生み出しています。さらに、固形腫瘍検査市場の開拓は、技術的な改善、複数の製品の導入、主要な競合他社の買収、提携、契約戦術によっても促進されています。例えば、ロシュは2021年8月、VENTANA MMR RxDx Panelが米国食品医薬品局（FDA）の承認を取得したと発表し、どの患者が特定の治療や標的治療から恩恵を受ける可能性が最も高いかを特定する検査を通じて、個別化医療への同社の取り組みを推進します。DNAミスマッチ修復（dMMR）異常のある固形がん患者の特定に役立つ最初のコンパニオン診断検査は、VENTANA MMR RxDx Panelです。しかし、固形腫瘍検査はコストが高いため、2023年から2030年の予測期間を通じて市場成長を阻害します。

固形腫瘍検査の世界市場調査において考慮された主要地域は、アジア太平洋地域、北米、欧州、中南米、その他の地域です。北米は、重要な市場プレイヤーの普及と、同地域における疾患の頻度の増加により、収益面で市場を独占しています。一方、アジア太平洋地域は、対象人口や老年人口の増加、製品開発協力の増加、主要プレイヤーの地理的拡大、非営利団体や政府機関による市場への積極的参加など、さまざまな要因から、予測期間中に最も高いCAGRを示すと予測されます。

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界市場・セグメント別市場の推定・予測、2020-2030年
  • 主な動向
  • 調査手法
  • 調査の前提条件

第2章 固形腫瘍検査の世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 本調査の対象範囲
  • 本調査の対象年
  • 通貨換算レート

第3章 固形腫瘍検査の世界市場力学

  • 固形腫瘍検査市場の影響分析（2020年～2030年）
    • 市場促進要因
      • がんの有病率の増加
      • 卵巣がん、膵臓がん、前立腺がんにおける新製品の承認
    • 市場の課題
      • 固形腫瘍検査の高コスト
    • 市場の機会
      • がん啓発のための政府イニシアチブの増加
      • 個別化治療の進展
      • 発達したヘルスケアインフラの存在

第4章 世界の固形腫瘍検査市場の産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響度分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの提言と結論

第5章 固形腫瘍検査の世界市場：タイプ別

  • 市場スナップショット
  • 固形腫瘍検査の世界市場：タイプ別実績-ポテンシャル分析
  • 固形腫瘍検査の世界市場、タイプ別推定・予測：2020年～2030年
  • 固形腫瘍検査の世界市場、サブセグメント別分析
    • 遺伝子検査
    • 従来型検査

第6章 固形腫瘍検査の世界市場：用途別

  • 市場スナップショット
  • 固形腫瘍検査の世界市場：用途別実績・ポテンシャル分析
  • 固形腫瘍検査の世界市場、用途別推定・予測2020-2030
  • 固形腫瘍検査の世界市場、サブセグメント別分析
    • 前立腺
    • 乳房
    • 結腸直腸
    • 子宮内膜
    • 肺
    • メラノーマ
    • 脳
    • その他

第7章 固形腫瘍検査の世界市場：エンドユース別

  • 市場スナップショット
  • 固形腫瘍検査の世界市場：エンドユース別、実績 - ポテンシャル分析
  • 固形腫瘍検査の世界市場、エンドユース別推定・予測2020-2030
  • 固形腫瘍検査市場、サブセグメント別分析
    • 病院
    • 製薬会社、バイオテクノロジー企業
    • 受託研究機関
    • 学術研究機関

第8章 固形腫瘍検査の世界市場：地域別分析

  • 主要国
  • 主な新興国
  • 固形腫瘍検査市場、地域別市場スナップショット
  • 北米
    • 米国
      • タイプ別推定・予測、2020-2030年
      • アプリケーション別の推定・予測、2020-2030年
      • エンドユースの内訳の推定と予測、2020-2030年
    • カナダ
  • 欧州固形腫瘍検査市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋地域の固形腫瘍検査市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの固形腫瘍検査市場スナップショット
    • ブラジル
    • メキシコ
  • 世界のその他の地域

第9章 競合情報

  • 主要企業のSWOT分析
  • 主な市場戦略
  • 企業プロファイル
    • Qiagen
      • 主要情報
      • 概要
      • 財務情報（データの入手が可能な場合のみ）
      • 製品概要
      • 最近の動向
    • Quest Diagnostics Inc
    • Abbott Laboratories
    • Agilent Technologies Inc.
    • Biocare Medical LLC
    • F. Hoffmann-La Roche AG
    • Illumina, Inc.
    • MedGenome Labs Private Ltd
    • Myriad Genetics, Inc.
    • Thermo Fisher Scientific, Inc

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Solid Tumor Testing Market, report scope
  • TABLE 2. Global Solid Tumor Testing Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Solid Tumor Testing Market estimates & forecasts by Type 2020-2030 (USD Billion)
  • TABLE 4. Global Solid Tumor Testing Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 5. Global Solid Tumor Testing Market estimates & forecasts by End Use 2020-2030 (USD Billion)
  • TABLE 6. Global Solid Tumor Testing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Solid Tumor Testing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Solid Tumor Testing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Solid Tumor Testing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Solid Tumor Testing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Solid Tumor Testing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Solid Tumor Testing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Solid Tumor Testing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Solid Tumor Testing Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Solid Tumor Testing Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia Solid Tumor Testing Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA Solid Tumor Testing Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Solid Tumor Testing Market
  • TABLE 71. List of primary sources, used in the study of global Solid Tumor Testing Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Solid Tumor Testing Market, research methodology
  • FIG 2. Global Solid Tumor Testing Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Solid Tumor Testing Market, key trends 2022
  • FIG 5. Global Solid Tumor Testing Market, growth prospects 2023-2030
  • FIG 6. Global Solid Tumor Testing Market, porters 5 force model
  • FIG 7. Global Solid Tumor Testing Market, pest analysis
  • FIG 8. Global Solid Tumor Testing Market, value chain analysis
  • FIG 9. Global Solid Tumor Testing Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Solid Tumor Testing Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Solid Tumor Testing Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Solid Tumor Testing Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Solid Tumor Testing Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Solid Tumor Testing Market, regional snapshot 2020 & 2030
  • FIG 15. North America Solid Tumor Testing Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Solid Tumor Testing Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Solid Tumor Testing Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Solid Tumor Testing Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Solid Tumor Testing Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Solid Tumor Testing Market is valued at approximately USD 25.47 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 7.0% over the forecast period 2023-2030. A solid tumour is characterized as an uncontrolled cell development that does not include fluids or cysts. For the early-stage diagnosis of tumors, solid tumour testing is used. Despite significant research into the biology of solid tumors and the development of tests for the detection of solid tumors, they remain one of the main causes of death. Genetic and conventional testing are the two methods used to diagnose solid tumors. The Solid Tumor Testing market is expanding because of factors such as the rising prevalence of cancer and new product approvals in ovarian, pancreatic, and prostate cancers.

The rising prevalence of cancer globally is fostering market growth, according to estimates from the International Agency for Research on Cancer (IARC), it is estimated worldwide burden of cancer is projected to reach 27.5 million new cases by 2040 from 1.9 million new cases in the year 2021. In addition, Increasing Government Initiatives for Cancer Awareness, and the presence of developed healthcare infrastructure are creating lucrative growth in the market. Moreover, the development of the solid tumour testing market is also fueled by technical improvements, the introduction of several products, and key competitors' acquisition, partnership, and agreement tactics. For instance, Roche announced in August 2021 that the VENTANA MMR RxDx Panel has received approval from the U.S. Food and Drug Administration (FDA), advancing the company's commitment to personalized healthcare through tests that identify which patients are most likely to benefit from particular and targeted therapies. The first companion diagnostic test to help with patient identification whose solid tumors are defective in DNA mismatch repair (dMMR) is the VENTANA MMR RxDx Panel. However, the high cost of Solid Tumor Testing stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Solid Tumor Testing Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue due to the prevalence of important market players and the increased frequency of diseases in the area. On the other hand, the Asia Pacific region is projected to have the highest CAGR during the forecast period due to a variety of factors, such as an increase in the target and geriatric populations, an increase in the number of product development collaborations, the geographic expansion of major players, and active participation by nonprofit and governmental organisations in the market..

Major market player included in this report are:

  • Qiagen
  • Quest Diagnostics Inc
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Biocare Medical LLC
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • MedGenome Labs Private Ltd
  • Myriad Genetics, Inc.
  • Thermo Fisher Scientific, Inc

Recent Developments in the Market:

  • In December 2022, Leading biotechnology firm DragonFly Therapeutics, Inc. reported that the Phase-2 research of HER2 targeting TriNKET in patients with advanced solid tumors had dosed its first patient.
  • In November 2022, CatalYm c announced it raised USD 54.77 million to boost its solid tumor trials and develop new testing.

Global Solid Tumor Testing Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Type, Application, End Use Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East& Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
  • The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Type:

  • Genetic Testing
  • Conventional Testing

By Application:

  • Prostate
  • Breast
  • Colorectal
  • Endometrial
  • Lung
  • Melanoma
  • Brain
  • Others

By End Use:

  • Hospitals
  • Pharmaceutical and biotechnology companies
  • Contract research organizations
  • Academic research institutions

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Solid Tumor Testing Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Solid Tumor Testing Market, by Type, 2020-2030 (USD Billion)
    • 1.2.3. Solid Tumor Testing Market, by Application, 2020-2030 (USD Billion)
    • 1.2.4. Solid Tumor Testing Market, by End Use, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Solid Tumor Testing Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Solid Tumor Testing Market Dynamics

  • 3.1. Solid Tumor Testing Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of cancer
      • 3.1.1.2. New product approvals in ovarian, pancreatic, and prostate cancers.
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Solid Tumor Testing
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing Government Initiatives for Cancer Awareness
      • 3.1.3.2. Rising development of personalised treatment
      • 3.1.3.3. Presence of developed healthcare infrastructure

Chapter 4. Global Solid Tumor Testing Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Solid Tumor Testing Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Solid Tumor Testing Market by Type, Performance - Potential Analysis
  • 5.3. Global Solid Tumor Testing Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
  • 5.4. Solid Tumor Testing Market, Sub Segment Analysis
    • 5.4.1. Genetic Testing
    • 5.4.2. Conventional Testing

Chapter 6. Global Solid Tumor Testing Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Solid Tumor Testing Market by Application, Performance - Potential Analysis
  • 6.3. Global Solid Tumor Testing Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 6.4. Solid Tumor Testing Market, Sub Segment Analysis
    • 6.4.1. Prostate
    • 6.4.2. Breast
    • 6.4.3. Colorectal
    • 6.4.4. Endometrial
    • 6.4.5. Lung
    • 6.4.6. Melanoma
    • 6.4.7. Brain
    • 6.4.8. Others

Chapter 7. Global Solid Tumor Testing Market, by End Use

  • 7.1. Market Snapshot
  • 7.2. Global Solid Tumor Testing Market by End Use, Performance - Potential Analysis
  • 7.3. Global Solid Tumor Testing Market Estimates & Forecasts by End Use 2020-2030 (USD Billion)
  • 7.4. Solid Tumor Testing Market, Sub Segment Analysis
    • 7.4.1. Hospitals
    • 7.4.2. Pharmaceutical and biotechnology companies
    • 7.4.3. Contract research organizations
    • 7.4.4. Academic research institutions

Chapter 8. Global Solid Tumor Testing Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Solid Tumor Testing Market, Regional Market Snapshot
  • 8.4. North America Solid Tumor Testing Market
    • 8.4.1. U.S. Solid Tumor Testing Market
      • 8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. End Use breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Solid Tumor Testing Market
  • 8.5. Europe Solid Tumor Testing Market Snapshot
    • 8.5.1. U.K. Solid Tumor Testing Market
    • 8.5.2. Germany Solid Tumor Testing Market
    • 8.5.3. France Solid Tumor Testing Market
    • 8.5.4. Spain Solid Tumor Testing Market
    • 8.5.5. Italy Solid Tumor Testing Market
    • 8.5.6. Rest of Europe Solid Tumor Testing Market
  • 8.6. Asia-Pacific Solid Tumor Testing Market Snapshot
    • 8.6.1. China Solid Tumor Testing Market
    • 8.6.2. India Solid Tumor Testing Market
    • 8.6.3. Japan Solid Tumor Testing Market
    • 8.6.4. Australia Solid Tumor Testing Market
    • 8.6.5. South Korea Solid Tumor Testing Market
    • 8.6.6. Rest of Asia Pacific Solid Tumor Testing Market
  • 8.7. Latin America Solid Tumor Testing Market Snapshot
    • 8.7.1. Brazil Solid Tumor Testing Market
    • 8.7.2. Mexico Solid Tumor Testing Market
  • 8.8. Rest of The World Solid Tumor Testing Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Qiagen
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Quest Diagnostics Inc
    • 9.3.3. Abbott Laboratories
    • 9.3.4. Agilent Technologies Inc.
    • 9.3.5. Biocare Medical LLC
    • 9.3.6. F. Hoffmann-La Roche AG
    • 9.3.7. Illumina, Inc.
    • 9.3.8. MedGenome Labs Private Ltd
    • 9.3.9. Myriad Genetics, Inc.
    • 9.3.10. Thermo Fisher Scientific, Inc

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption